Suchergebnisse - "Gromowski, Gregory D"

PubPharm (86)

1

Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain

enthalten in: Structure (London, England : 1993) | 2024

von Sankhala, R. | Dussupt, V. | Chen, W. | +42

2

Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques

enthalten in: Nature communications | 2024

von Sankhala, R. | Lal, K. | Jensen, J. | +48

3

Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA : a phase 1, randomised, double-blind, placebo-controlled clinical trial

enthalten in: The Lancet. Infectious diseases | 2023

von Koren, M. | Lin, L. | Eckels, K. | +26

CommentIn: Lancet Infect Dis. 2023 Oct;23(10):1103-1105. - PMID 37390837

4

Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes

enthalten in: Cell reports | 2023

von Sankhala, R. | Dussupt, V. | Donofrio, G. | +40

5

Humoral immune responses associated with control of SARS-CoV-2 breakthrough infections in a vaccinated US military population

enthalten in: EBioMedicine | 2023

von Gromowski, G. | Cincotta, C. | Mayer, S. | +15

6

Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity

enthalten in: Journal of virology | 2023

von Jensen, J. | Sankhala, R. | Dussupt, V. | +29

7

Impact of prior dengue virus infection on Zika virus infection during pregnancy in marmosets

enthalten in: Science translational medicine | 2023

von Kim, I. | Tighe, M. | Clark, M. | +16

8

SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies

enthalten in: NPJ vaccines | 2023

von Shrivastava, S. | Carmen, J. | Lu, Z. | +25

9

Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates

enthalten in: Nature | 2023

von Goethals, O. | Kaptein, S. | Kesteleyn, B. | +41

CommentIn: Nat Rev Drug Discov. 2023 May;22(5):355. - PMID 37020012

10

Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates

enthalten in: Nature | 15 March 2023

von Goethals, O. | Kaptein, S. | Kesteleyn, B. | +41

1
2
3
4
5
6
7
8
9
Nächster »
[9]